SCHEDULE: Vanguard Group Discloses 5.19% Stake in SANUWAVE Health Inc.

The Vanguard Group has reported beneficial ownership of 5.19% of SANUWAVE Health Inc.'s Common Stock as of June 30, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 444,806 shares of SANUWAVE Health Inc. Common Stock.
• This ownership represents 5.19% of the total class of securities.
• The filing indicates The Vanguard Group holds 0 shares with sole voting power, 6,833 shares with shared voting power, 434,736 shares with sole dispositive power, and 10,070 shares with shared dispositive power.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a major institutional investor like Vanguard has disclosed a significant stake, which can be interpreted as a vote of confidence. However, the filing itself is purely factual and does not contain operational or financial performance details.

Positives

• The disclosure of a significant stake by a major institutional investor like The Vanguard Group may signal confidence in SANUWAVE Health Inc.

Negatives

• No negative operational or financial information is disclosed in this beneficial ownership report.

Risks

• This filing does not detail specific operational or financial risks for SANUWAVE Health Inc.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding SANUWAVE Health Inc.'s future performance or operations.

Industry Context

This filing is a standard disclosure of beneficial ownership by a large institutional asset manager, The Vanguard Group, in a publicly traded company. It reflects an investment position rather than a strategic industry move or operational update.

Comparison to Industry Standards

• This filing is a routine Schedule 13G, which is a standard regulatory disclosure for institutional investors acquiring more than 5% of a company's stock, indicating compliance with SEC reporting requirements.
• The Vanguard Group's investment in SANUWAVE Health Inc. is consistent with its typical strategy of holding diversified portfolios across various industries, including healthcare technology.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder may increase investor confidence and potentially influence trading activity.
• Management: Awareness of a large institutional holder may influence strategic decisions, though Vanguard states its holding is for ordinary course of business and not for control.

Key Dates

Keywords

SANUWAVE Health, Vanguard Group, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor